Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...

Two research articles published in Nature Genetics shed new light on the cellular complexity of glioblastoma, the most ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

Join Drs Tania Jain and Prithviraj Bose as they discuss the available JAK inhibitors and how they use them to treat myelofibrosis.

A team of Brazilian researchers has developed an innovative CAR-T cell therapy that showed positive results in patients with ...

A new Brazilian-developed CAR-T cell therapy has shown extraordinary results in treating refractory CD30+ lymphoma, including ...

However, leukemia originates in the bone marrow and spreads through the blood, while lymphoma originates in the spleen ... cells do not appear in the blood circulating in your body. Though they also ...

With average T-bill yields at 4.359%, Buffett prioritizes stable returns while awaiting compelling investment opportunities. However, its position is much smaller than Berkshire’s. Buffett ...

If you or someone you love lives with sickle cell, you already know the story. The ER visits. The unpredictable pain. The fatigue that doesn’t go away. The fear of strokes, infections, and organ ...

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...

If you or a loved one has diffuse large B-cell lymphoma (DLBCL) that is no longer responding to treatment or came back after treatment, chimeric antigen receptor (CAR) T-cell therapy may be an option.